News
March 27, 2026: Hallux Poster Exhibit Abstract on Dermatophytoma Treatment at 2026 American Academy of Dermatology Annual Meeting
January 14, 2026: FDA Approves IND for Hallux Subungual Gel 42%: A New Approach Enabling Physicians to Treat Toenail Fungus at the Point-of-Care
February 20, 2025 A New Innovative and Transformational Approach to Treatment of Toenail Onychomycosis: An Open Phase 2 Study
February 28, 2023: Hallux Reaches Enrollment Target In Onychomycosis Trial
September 22, 2022: Hallux Inc Opens Third Clinical Site To Evaluate Novel Onychomycosis Product Candidate
July 7, 2022: Hallux Inc Opens Second Clinical Site To Evaluate Novel Onychomycosis Product Candidate
May 18, 2022: Seth M. Birnbaum Joins Pharma Company Hallux Inc. Board Of Directors
April 6, 2022: Hallux Inc. Announces Closing Of $9.4m Series A-2 Financing
January 12, 2022: Hallux Starts Phase 2 Clinical Study Of Novel Subungual Gel For Onychomycosis
November 8, 2016: Hallux Announces Start Of Phase 2 Clinical Trial

